Received Sep 29, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPA | HEP A (VAQTA) | MERCK & CO. INC. | 2 | Y013120 | OT |
no symptoms; an adult patient received a pediatric dose of VAQTA that was administered on 9/11/2025; This spontaneous report was received from a nurse and refers to an adult patient of unknown age and gender. The patient's medical history, concurrent conditions, concomitant therapies, and drug reactions/allergies were not reported. On 11-Sep-2025, the patient was vaccinated with a pediatric dose of hepatitis A vaccine, inactivated (VAQTA) injection (lot #Y013120, expiration date: 26-Dec-2025) (25 units intramuscularly/Second dose of the series), dose number 2, administered by intramuscular route as prophylaxis by health professional (Underdose). The patient had no symptoms (no adverse event).
Comments: unknown